Navigation Links
Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta Celebrates $50 Million of Goodwill
Date:8/19/2009

ATLANTA, Aug. 19 /PRNewswire/ -- The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta today kicks off Pediatric Cancer and Sickle Cell Awareness Month by announcing that its primary benefactor, Aflac, has surpassed $50 million in donations to the fight against pediatric cancer and blood disorders. September is Pediatric Cancer and Sickle Cell Awareness Month, and cancer is the leading cause of death by disease for children under 15 in America.

Contributions to the Aflac Cancer Center help the center treat more than 350 new cancer patients every year. The hospital also performs more than 50 bone marrow transplants each year, making it the leading BMT program in the country. In 2008, the Aflac Cancer Center treated a total of 6,504 patients.

"We could not do the innovative research nor provide the quality of care that patients need without the generous support of good-hearted people who are committed to eradicating childhood cancer and blood disorders," Dr. William G. Woods, director of the Aflac Cancer Center and Professor with the Emory University School of Medicine. "Aflac's support enables us to recruit the most brilliant and dedicated researchers who are developing life-saving treatments for children at the Aflac Cancer Center and across the nation."

With 1,635 active cases, the facility maintains the largest pediatric sickle cell disease program in America, curing more children of sickle cell disease than anywhere in the nation. Sickle cell is an extraordinarily painful disease that attacks internal organs through the blood stream. Sickle Cell Disease is often referred to as an orphan disease. An orphan disease is one tha
'/>"/>

SOURCE Aflac Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac to Sponsor Iron Girl
8. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
9. Aflac Incorporated Announces Fourth Quarter Results
10. Training Magazine Applauds Aflacs Employee Learning Programs
11. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Deirdre Byrne to lead the firm’s Interim Leadership division as senior ... in healthcare consulting, Byrne will assume her duties at B. E. ... ... 2009 -- B. E. Smith recently hired Deirdre Byrne ... A seasoned executive with nearly 20 years of experience in healthcare ...
(Date:12/17/2009)... -- It,s customary for the holidays to wreak havoc ... of year, workouts often get short-changed and nutrition is ... trainer Valerie Waters, it is not impossible to enjoy ... why California Raisins and Waters have teamed up to ... the holiday season and get a jump start on ...
(Date:12/17/2009)... ( www.CareTech.com ), an information technology (IT) and web ... was named Best in KLAS, Extensive IT Outsourcing ... in KLAS Awards: Software & Professional Services report. ... in key market segments including EMRs, cardiology systems, IT ... performance score was 90.3 on a 100-point scale and ...
(Date:12/17/2009)... The recently opened Laser Spine ... the community in full force this holiday season, as ... 13th, benefiting the Arthritis Foundation, a non-profit organization dedicated ... event boasted 1,500 attendees, spotlighting LSI,s passion for their ... renowned, national fundraiser and a festive way to get ...
(Date:12/17/2009)... -- AlloSource, one of the nation,s largest non-profit providers ... in surgical procedures and the world,s largest processor of ... has been selected as a finalist in the 2010 ... Samaritan Institute category honoring non-profits. This is the second ... as a finalist by the annual awards program, now ...
Breaking Medicine News(10 mins):Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 2Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 3Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 2Health News:CareTech Solutions Named 2009 'Best in KLAS' for Extensive Information Technology Outsourcing for the Second Consecutive Year 3Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 2Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 3
... Nov. 3 Pregis Corporation, a leading,international ... and specialty packaging solutions, will conduct an ... quarter results on Friday,November 14, 2008 at ... 800-591-6942;,International: 617-614-4909; Participant Passcode: 68623125. A replay ...
... Orthopaedic osteoporosis management is a crucial element in ... Most patients who,suffer a hip fracture are referred ... However, according to a study published in the,November ... Joint Surgery,( http://www.ejbjs.org ), an osteoporosis management ...
... LifeNet Health,a leading allograft bio-implant company, ... United States Food and Drug Administration (FDA) ... technology., LifeNet Health received clearance for ... donor cells from cardiovascular tissues,while retaining the ...
... Nov. 3 BioMarin Pharmaceutical,Inc. (Nasdaq: BMRN ... Clinical,Assessment Program (MorCAP) for patients with the lysosomal ... A Syndrome. MorCAP is,designed to augment available data ... and other parameters in affected patients.,BioMarin expects to ...
... GeneThera, Inc.,(Pink Sheets: GTHR), As a service and responsibility ... the future of the company.,GeneThera is making a pivotal ... marketing and revenue generating entity., The company strategy ... (July, 2008) had been one of research only. We ...
... Ala., Nov. 3 BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ... Executive Officer of BioCryst, will present,a corporate update at ... York on Monday, November 10, 2008 at 9:55 a.m. ... at the Palace Hotel,in New York, New York., ...
Other Medicine News:Health News:Treating Osteoporosis After Hip Fracture 2Health News:Treating Osteoporosis After Hip Fracture 3Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 2Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 3Health News:BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome 4Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 2Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 3Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 4Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 5Health News:GeneThera - CHANGING DIRECTIONS - an Update to Shareholders 6Health News:BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 3
(Date:12/16/2009)... -- According to Millennium Research Group (MRG), the ... the US minimally invasive spinal fusion market will ... over 12% through 2014, reimbursement concerns in certain ... which previously had been forecast at almost 20%. ... Spine Technologies 2010 report finds ...
(Date:12/16/2009)... Inc., a Johnson & Johnson (NYSE: ... surgical care, and Acclarent, Inc., a privately held ... commercializing devices that address conditions affecting the ear, ... merger agreement whereby Ethicon will acquire Acclarent in ... of estimated cash on hand at time of ...
(Date:12/16/2009)... at,deCODE genetics, Inc. (Nasdaq: DCGN ) publish in ... a common single-letter variant in the sequence of,the ... susceptibility to type 2,diabetes (T2D). The impact of ... unusual:,if an individual inherits it from their father, ... 30% compared to those who inherit the non ...
Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4New Bone Building Drug Promising Against Prostate Cancer 54219 1New Bone Building Drug Promising Against Prostate Cancer 54219 2New Bone Building Drug Promising Against Prostate Cancer 54219 3Jefferson Headache Center study shows novel orally inhaled migraine therapy effective 54216 1Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 1Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 2Aging with GRACE 3A New health care delivery model improves outcomes saves money 54213 3
... Women with postmenopausal,osteoporosis receiving once-monthly Boniva(R) ... mineral density (BMD) to those,receiving once-weekly Fosamax(R) ... at the 29th Annual Meeting of the ... The study, called MOTION (Monthly Oral Therapy ...
... CHICAGO, Sept. 19 Targanta Therapeutics Corporation,today ... the in vitro,activity of its lead antibiotic ... against a variety of susceptible and resistant ... presented today at the 47th,Annual Interscience Conference ...
Other Medicine Technology:New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 2New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 3New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis 4Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 2Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 3Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 4Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: